Contact us

Enquiries

Adverse event reporting

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please contact the partner responsible for distribution in your country.

For reporting adverse events within Europe Union please contact local distributor or Recordati

RecordatiHQ-Safety@recordati.it
+39 02 487871

For reporting adverse events within Middle East and North Africa (MENA) please contact…

pharmacovigilance@blgx.net
+961 9 222 050 ext 286

JavaScript is not enabled.

The Kowa Corporate website uses JavaScript for some of its features. Please enable it in your browser settings.

You are now leaving the kowapharmaceuticals.eu website.

This link will take you to a third party website to which our Privacy policy does not apply. You are solely responsible for your interactions with any third party website. We encourage you to read the privacy policy of every website you visit.

CONTINUE TO THIRD PARTY WEBSITE

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

RecordatiHQ-Safety@recordati.it
+39 02 487871

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

pharmacovigilance@blgx.net
+961 9 222 050 ext 286